Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
View Patent ↗Aspects of the invention provides methods for preparing and using adipose-tissue-derived stem and progenitor cells, adipose-tissue-derived lymphatic endothelial cells, and cells capable of differentiating into lymphatic endothelial cells to treat disorders of the lymphatic system and to modulate expansion, repair, and/or regeneration of the lymphatic system. The invention further provides using adipose-tissue-derived lymphatic endothelial cells and cells capable of differentiating into lymphatic endothelial cells for delivery of therapeutic agents to tumor cells as a means for treating malignant disease, and assays to screen for drugs that modulate lymphatic system expansion, repair or regeneration.
1. A method of lymphatic endothelial cell (LEC) and pre-LEC transplantation in a mammal comprising:
identifying a mammal in need of LECs or pre-LECs; and
providing an isolated population of adipose-derived cells comprising lymphatic endothelial cells (LECs) and pre-LECs, wherein greater than 5% of said population of adipose-derived cells express FLT-4, to said identified mammal.
2. The method of claim 1 , wherein said isolated population of adipose-derived cells is mixed with a biological material, an additive, a medical device, a prosthetic, a cell differentiation factor, a growth promoter, an immunosuppressive agent, an anti-apoptosis agent, a biological tissue, a tissue graft, a portion of unprocessed adipose tissue, a collagen, a population of adipose-derived stem cells, a population of adipose-derived endothelial cells, or a population of adipose derived progenitor cells.
3. The method of claim 1 , further comprising assessing said mammal for induction of lymphatic cell proliferation, lymphatic cell expansion, lymphatic vessel formation, or lymphatic tissue formation.
4. The method of claim 1 , wherein said cell transplantation accompanies a breast augmentation procedure.
5. A method of inducing expansion of lymph vessels in a mammal comprising:
identifying a mammal in need of an expansion of lymph vessels; and
providing an isolated population of adipose-derived cells comprising lymphatic endothelial cells (LECs) and pre-LECs, wherein greater than 5% of said population of adipose-derived cells express FLT-4, to said identified mammal.
6. The method of claim 5 , wherein said isolated population of adipose-derived cells is mixed with a biological material, an additive, a medical device, a prosthetic, a cell differentiation factor, a growth promoter, an immunosuppressive agent, an anti-apoptosis agent, a biological tissue, a tissue graft, a portion of unprocessed adipose tissue, a collagen, a population of adipose-derived stem cells, a population of adipose-derived endothelial cells, or a population of adipose derived progenitor cells.
7. The method of claim 5 , further comprising assessing said mammal for one or more of the following: induction of lymphatic cell proliferation, lymphatic cell expansion, lymphatic vessel formation, and lymphatic tissue formation.
8. The method of claim 5 , wherein said providing step accompanies a breast augmentation procedure.